0.645
-0.61 (-48.40%)
AIStockmoo 评分
| 价值 30% | -2.3 |
| 来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 | NA |
| 相对估值 参考 | NA |
| 隐含增长 参考 | NA |
| 历史估值 参考 | NA |
| 盈利能力弱。短期流动性偏紧。现金流为正。 参考 | |
| 资本回报 参考 | NA |
| 时机 30% | -4.7 |
| 来自我们对走势图的 AI 技术分析。 参考 | NA |
| 过去一年呈下降趋势。股价远低于52周高点。 参考 | |
| K线形态 参考 | NA |
| 您持有期的趋势 参考 | NA |
| 市场情绪 20% | 0.0 |
| 近期没有目标价,因此依据目标价的调整方向。 参考 | |
| 新闻情绪 参考 | NA |
| 聪明钱 20% | 2.3 |
| 内部交易活动 参考 | NA |
| 机构在最新13F申报中净+2.26%的股份:26家增持,28家减持(截至30 Sep 2026的季度)。 参考 | |
| 空头持仓从31 Aug到30 Oct 2026变化-16.8%,回补天数3.4天(FINRA)。 参考 | |
| 市场和行业状况中性。 | |
| 市场环境偏谨慎。 参考 | |
| 行业表现优于大市。 | |
| 各支柱方向一致,评分因此加强。 | |
| 不计入评分 | |
| 股价低于其52周平均水平。5年来下跌。 参考 | |
| 短、中、长期趋势均向下。短期动能下降。 参考 | |
| 支撑与阻力没有明确信号。 参考 | |
| 最终评分 | -1.72 |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - General (US) | 混合的 | 看涨 |
| Drug Manufacturers - General (全球的) | 混合的 | 看涨 | |
| 股票 | Scilex Holding Company | 混合的 | 混合的 |
相关股票
| 股票 | 市值 | DY | P/E(TTM) | P/B |
|---|---|---|---|---|
| SCLX | - | - | - | - |
| SNY | - | 5.10% | - | 1.40 |
| AMGN | - | 2.17% | - | 17.55 |
| GILD | - | 1.94% | - | 16.00 |
| GRFS | - | 1.08% | - | 0.900 |
| BIIB | - | - | - | 1.98 |
|
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - General |
| 投资方式 | Small Value |
| 内部持股比例 | 21.58% |
| 机构持股比例 | 18.55% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Ashton Thomas Private Wealth, Llc | 30 Sep 2026 | 23,832 |
该时间范围内无数据。
该时间范围内无数据。
机构
机构持股比例: 13.03%
| 持仓变动 | 机构数 | 股数 |
|---|---|---|
| 增持 | 26 | 153,919 |
| 减持 | 28 | 32,382 |
| 新建仓 | 17 | 61,923 |
| 清仓 | 14 | 2,669 |
来源:经Nasdaq的SEC 13F申报,最新申报截至30 Sep 2026。申报在每季结束后45天内陆续提交。
空头持仓
| 结算日 | 股数 | 回补天数 |
|---|---|---|
| 30 Oct 2026 | 132,205 | 3.4 |
| 15 Oct 2026 | 148,382 | 2.6 |
| 30 Sep 2026 | 171,151 | 5.8 |
| 15 Sep 2026 | 176,711 | 5.9 |
| 31 Aug 2026 | 158,922 | 3.1 |
| 14 Aug 2026 | 152,585 | 4.0 |
来源:经Nasdaq的FINRA空头持仓数据,每月公布两次。
| 日期 | 类型 | 细节 |
|---|---|---|
| 28 Oct 2026 | Yahoo Finance |
Datavault AI Stock Jumps 31% Even as Its Bitcoin Sits Stuck at Biconomy
Its restatement takes every reported bitcoin off the books, including 837 BTC Scilex agreed to buy in June. No definitive deal has been disclosed. |
| 28 Oct 2026 | Yahoo Finance |
Bitcoin Treasury Datavault AI Says It Can’t Access Its BTC, Stock Tanks
Datavault AI says it has been unable to withdraw its Bitcoin from Biconomy since June and will restate four financial reports tied to a $150 million Scilex deal. |
| 28 Oct 2026 | Yahoo Finance |
$150 Million Bitcoin Controversy Crashes a Nasdaq Stock
A $150 million Bitcoin deal left Datavault AI unable to reach its coins. Its stock lost half its value. What happened? |
| 28 Oct 2026 | Yahoo Finance |
Datavault AI Says It Can’t Access Its Bitcoin Holdings
Crypto treasury firm Datavault AI (NASDAQ: $DVLT) says it is unable to access a large portion of its Bitcoin (CRYPT… |
| 20 Aug 2026 | Yahoo Finance |
Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.
The St. James Bank & Trust Company Ltd. ("St. James"), Omega & Corinth Group Ltd. and Marc Wade today announced that the U.S. District Court has granted their motion to compel arbitration and stay all court proceedings in California brought by Scilex Holding Company ("Scilex").. |
投资组合